Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy, first isolated in 1945. These peptides disrupt both gram positive and gram negative bacteria by interfering with cell wall and peptidoglycan synthesis. Bacitracin is used as a topical preparation (since it is toxic and has poor oral bioavailability). In terms of adverse reactions only, in comparison with bacitracin, white petrolatum possesses an equally low infection rate and minimal risk for induction of allergy.
Antigen Description
Bacitracin is a mixture of related cyclic polypeptides produced by a member of the Bacillus subtilis group. Unlike most antibiotics its use is limited in oral administration and typical methods of application are by adsorption through the skin where the drug degrades the bacterial cell wall in Gram positive bacteria by blocking the dephosphorylation of the C55-isoprenyl pyrophosphate, an important molecule in the process of building the bacterial cell wall. Its main application is for fowl animals such as chickens in the form of an antibiotic drug and no MRLs have yet been established for this drug.
Keywords
Bacitracin
Citations
Publication ()
Have you cited DAG1043 in a publication? Let us know and earn a reward for your research.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.